NCT06722937

Brief Summary

The purpose of this observational study was to understand the differences in clinical features and mechanisms of keratoconus between children and adults. The main questions it aimed to answer as follows: (1) to understand the characteristics of keratoconus in Chinese children. (2) to observe corneal stromal cells at the cytological level using in vivo corneal laser confocal microscopy and explore the pathogenesis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 14, 2023

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

November 26, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 9, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 13, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 13, 2025

Completed
Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

2 years

First QC Date

November 26, 2024

Last Update Submit

December 3, 2024

Conditions

Keywords

keratoconuspediatricCorneal biomechanicscollagen

Outcome Measures

Primary Outcomes (12)

  • Thinnest corneal thickness

    Measurement of the thinnest point corneal thickness using the Three-Dimensional Anterior Segment Analyzer.

    1 year

  • Kmax

    Measurement of the maximum keratometry from the anterior corneal surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.

    1 year

  • ISV

    Measurement of the index of surface variance of corneal front surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.

    1 year

  • IVA

    Measurement of the index of vertical asymmetry of the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.

    1 year

  • IHA

    Measurement of the index of height asymmetry of the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.

    1 year

  • IHD

    Measurement of the index of height decentration the corneal anterior surface using the Pentacam Three-Dimensional Anterior Segment Analyzer.

    1 year

  • CBI

    Measurement of the corvis biomechanical index of cornea using the Corneal Biomechanical Analyzer.

    1 year

  • TBI

    Measurement of the tomographical biomechanical index of cornea using the Corneal Biomechanical Analyzer.

    1 year

  • SPA1

    Measurement of the stiffness parameter at the first applanation of cornea using the Corneal Biomechanical Analyzer.

    1 year

  • SSI

    Measurement of the stress-strain index of cornea using the Corneal Biomechanical Analyzer.

    1 year

  • Corneal stromal cell density

    Measurement of the corneal stromal cell density using in vivo corneal confocal microscopy.

    1 year

  • Mutations in collagen related genes

    The expressions and mutations in collagen related genes(COL4A3, COL4A4 COL5A1, COL6A2, TGFBI, LOX, MMP9, TIMP1) using the DNA Sequencing Technology.

    1 year

Secondary Outcomes (4)

  • Frame best corrected visual acuity

    1 year

  • Spherical power

    1 year

  • Cylindrical power

    1 year

  • Axial length

    1 year

Study Arms (4)

Keratoconus group of children

Other: Observation

Keratoconus group of adult

Other: Observation

Control group of children

Other: Observation

Control group of adult

Other: Observation

Interventions

Observe the clinical natural changes of eye parameters of the subjects.

Control group of adultControl group of childrenKeratoconus group of adultKeratoconus group of children

Eligibility Criteria

Age10 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

Consistently enrolled subjects aged between 10 and 50 years old with keratoconus and myopic astigmatism who visited the refractive clinic from April 2023 to April 2024

You may qualify if:

  • ① Patients with keratoconus who visit the refractive clinic.
  • The height of the posterior corneal surface is greater than 16 microns under the Pentacam corneal topography.
  • ARTAve \< 424 microns, ARTMax \< 339 microns.
  • Clinical non-inflammatory or traumatic corneal thinning and corneal astigmatism.
  • Aged between 10 and 50 years old, no gender restrictions.
  • Agree to accept and complete follow-up examinations on time. ④ I and my guardian understand and agree to participate in this clinical trial and sign the informed consent form.

You may not qualify if:

  • ① There is a history of contact lens wearing in the last four weeks.
  • poor fixation and can not cooperate with the examination. ③ History of eye trauma and surgery (including corneal collagen cross-linking surgery).
  • History of other related eye diseases: corneal disease, glaucoma, retinal choroid disease, etc..
  • ⑤ severe eye diseases affecting imaging such as dry eye, conjunctivitis and pterygium.
  • ⑥ Any systemic disease affecting eye morphology and refractive interstitium.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhongshan Ophthalmic Center,Sun Yat-Sen University

Guangzhou, Guangdong, China

RECRUITING

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Venous blood DNA sequencing analysis

MeSH Terms

Conditions

Keratoconus

Interventions

Observation

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2024

First Posted

December 9, 2024

Study Start

April 14, 2023

Primary Completion

April 13, 2025

Study Completion

April 13, 2025

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

We will share our Study protocol, Statistical analysis plan, Informed consent form, Clinical study report.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
The IPD and supporting information will be permanently available (start date) on December 30, 2025.
Access Criteria
Any non-commercial scholars and institutions can apply to access the IPD and supporting information.

Locations